1 Min Read
Dec 8 (Reuters) - Spark Therapeutics Inc :
* Spark Therapeutics Inc - on December 2, 2016 entered into a license and option agreement with Selecta Biosciences Inc Source text (bit.ly/2gfykZ8) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.